AAPS PharmSciTech

, Volume 1, Issue 4, pp 26–34 | Cite as

A bioresorbable, polylactide reservoir for diffusional and osmotically controlled drug delivery

  • Sriramakamal Jonnalagadda
  • Dennis H. Robinson


The purpose of this study was to design and characterize a zero-order bioresorbable reservoir delivery system (BRDS) for diffusional or osmotically controlled delivery of model drugs including macromolecules. The BRDS was manufactured by casting hollow cylindrical poly (lactic acid) (PLA): polyethylene glycol (PEG) membranes (10×1.6 mm) on a stainless steel mold. Physical properties of the PLA:PEG membranes were characterized by solid-state thermal analysis. After filling with drug (5 fluorouracil [5FU] or fluorescein isothiocyanate [FITC]-dextranmannitol, 5:95 wt/wt mixture) and sealing with viscous PLA solution, cumulative in vitro dissolution studies were performed and drug release monitored by ultraviolet (UV) or florescence spectroscopy. Statistical analysis was performed using Minitab® (Version 12). Differential scanning calorimetry thermograms of PLA:PEG membranes dried at 25°C lacked the crystallization exotherms, dual endothermal melting peaks. and endothermal glass transition observed in PLA membranes dried at −25°C. In vitro release studies demonstrated zero-order release of 5FU for up to 6 weeks from BRDS manufactured with 50% wt/wt PEG (drying temperature, 25°C). The release of FITC dextrans of molecular weights 4400, 42 000, 148 000, and 464 000 followed zero-order kinetics that were independent of the dextran molecular weight. When monitored under different concentrations of urea in the dissolution medium, the release rate of FITC dextran 42 000 showed a linear correlation with the calculated osmotic gradient (Δπ). PEG inclusion at 25°C enables manufacture of uniform, cylindrical PLA membranes of controlled permeability. The absence of molecular weight effects and a linear dependence of FITC-dextran release rate on Δπ confirm that the BRDS can be modified to release model macromolecules by an osmotically controlled mechanism.

Key Words

Zero-order Reservoir PLA Osmotic Delivery Thermal Analysis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yang L, Fassihi R. Zero-order release kinetics of a selfcorrecting floatable asymmetric configuration drug delivery system.J Pharm Sci. 1996;85(2):170–173.CrossRefGoogle Scholar
  2. 2.
    Theeuwes F, Swanson D, Wong P, et al. Elementary osmotic pump for indomethacin.J Phanm Sci. 1983, 72(3):253–258.CrossRefGoogle Scholar
  3. 3.
    Kim CJ. Compressed donut-shaped tablets with zero-order release kinetics.Pharm Res. 1995;12(7):1045–48.CrossRefGoogle Scholar
  4. 4.
    Mishra DS, Yalkowsky SH. A flat circular hole device for zeroorder release of drugs: characterization of the moving dissolution boundary.Pharm Res. 1990;7(11):1195–97.CrossRefGoogle Scholar
  5. 5.
    Kun WY, Yalkowsky SH. Multiple-hole approach to zero-order release.J Pharm Sci. 1985;74(9):926–933.CrossRefGoogle Scholar
  6. 6.
    Hsieh DST, Rhine WD, Langer R. Zero-order controlled-release polymer matrices for micro and macromolecules.J Pharm Sci. 1983;72(1):17–22.CrossRefGoogle Scholar
  7. 7.
    Bayomi MA. Geometric approach for zero-orderrelease of drug: dispersed in an inert matrix.Pharm Res. 1994;11(6):914–916.CrossRefGoogle Scholar
  8. 8.
    Lee PI. Novel approach to zero-order drug delivery via immobilized nonuniform drug distribution in glassy hydrogels.J. Pharm Sci. 1984;73(10):1344–1347.CrossRefGoogle Scholar
  9. 9.
    Möckel JE, Lippold BC. Zero-order drug release from hydrocolloidmatrices.Pharm Res. 1993;10(7):1066–1070.CrossRefGoogle Scholar
  10. 10.
    Lindstedt B, Agnarsson G, Hjärtstam J. Osmotic pumping as a release mechanism for membrane-coated drug fomulations.Int J Pharm. 1989;564:261–268.CrossRefGoogle Scholar
  11. 11.
    Lopaschuk GD, Tahiliani AG, McNeill JH. Continuous longterm insulin delivery in diabetic rats utilizing implated osmotic minipumps.J Pharmacol Methods. 1982;9:71–75.CrossRefGoogle Scholar
  12. 12.
    Santus G, Baker RW. Osmotic drug delivery: a review of patnent literature.J Control Rel. 1995;35:1–21.CrossRefGoogle Scholar
  13. 13.
    Theeuwes F. Elementary osmotic pump.J Pharm Sci. 1975;64(12):1987–1991.CrossRefGoogle Scholar
  14. 14.
    Agarwal RK.Development and Evaluation of Bioresorbable Membranes for the Controlled Release of Tetracycline HCl into Intracrevicular Fluic [dissertation]. Omaha, NE: University of Nebraska Medical Center; 1994.Google Scholar
  15. 15.
    Marcotte N, Polk A, Goosen MF. Kinetics of protein diffusion from a poly(D,L- lactide) reservoir system.J Pharm Sci. 1990;79(5):407–410.CrossRefGoogle Scholar
  16. 16.
    Sato S, Kim SW. Macromolecular diffusion through polymer membranes.Inter J Pharm. 1984;22:229–225.CrossRefGoogle Scholar
  17. 17.
    Demirdere A, Kissel T, Siemann U, Sucker H. Permeability and release properties of bioresorbable polymers. Part I: Feasibility of reservoir systems.Eur J Biopharm. 1991;37(1):42–48.Google Scholar
  18. 18.
    Weast RC, Astle MJ.CRC Handbook of Chemistry and Physics. Boca Raton, FL: CRC Press, Inc.: 1981–1982.Google Scholar
  19. 19.
    Bershtein VA, Egorov VM.Differential Scanning Calorimetry of Polymers: Physics, Chemistry, Analysis, Technology: New York: Ellis Horword Ltd.; 1994.Google Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2000

Authors and Affiliations

  • Sriramakamal Jonnalagadda
    • 1
  • Dennis H. Robinson
    • 1
  1. 1.Department of Pharmaceutical SciencesCollege of PharmacyOmaha

Personalised recommendations